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Abstract
© 2016, Springer Science+Business Media New York.Breast cancer is the second most common
cancer in women, but chemotherapy and targeting antibodies possess certain side effects.
Today’s efforts are aimed to search of new effective methods of breast cancer treatment,
especially triple-negative breast cancer, which cannot be affected by conventional therapeutics.
Binase,  the RNase secreted by Bacillus  pumilus,  possesses unusual  biological  activities  as
selective anticancer agent inducing apoptosis in malignant cells. Many aspects of this activity
have been elucidated, but the details of its specific mechanisms remain unknown. Here, we
found for the first time that the sensitivity of breast cancer cells to binase was not connected
with the level of cellular RNA catalytic degradation. Gene expression analysis in different breast
cancer cell  lines and breast  cancer cells  from patient samples revealed that the PI3K/AKT
pathway activity could be considered as a potential marker of binase effectiveness.
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